Losartan attenuates endothelial hyperpermeability responses to VPF and high glucose but not angiotensin II [4]

Diabetologia

Volumn 45, Issue 2, 2002, Pages 291-292

  Donnelly, Richard ^a  

^a DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN; GLUCOSE; LOSARTAN; VASCULOTROPIN;

CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM; HUMAN; HUMAN CELL; LETTER; PERMEABILITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; LOSARTAN; LYMPHOKINES; PULMONARY ARTERY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036186539     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0748-7     Document Type: Letter

References (8)

1. Increased transendothelial permeation of albumin by high glucose concentration
2. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes
3. Inflammatory agonists that increase microvascular permeability in vivo stimulate cultured pulmonary microvessel endothelial cell contraction
4. Factors regulating the expression of vascular permeabilty/vascular endothelial growth factor by human vascular tissues
5. Endothelial cell monolayers as a model system to investigate dengue shock syndrome
6. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells
7. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells
8. The angiotensin type-2 receptor is anti-angiogenic and down-regulates VEGF and VEGFR-2 expression in a rodent model of retinopathy of prematurity